Getinge AB ser. B (GETIBs)

Currency in SEK
186.20
0.00(0.00%)
Delayed Data·
GETIBs is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
186.20186.20
52 wk Range
181.53227.40
Key Statistics
Bid/Ask
186.20 / 187.65
Prev. Close
186.2
Open
186.2
Day's Range
186.2-186.2
52 wk Range
181.53-227.4
Volume
-
Average Volume (3m)
1.27K
1-Year Change
-0.3079%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GETIBs Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory

Getinge AB ser. B News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
21/04/2026
EPS / Forecast
1.80 / 1.61
Revenue / Forecast
7.44B / 7.61B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 8.66%
Dividend Yield
2.55%
Industry Median 1.96%
Annualised payout
4.75
Paid annually
5-Years Growth
+9.63%
Growth Streak

Compare GETIBs to Peers and Sector

Metrics to compare
GETIBs
Peers
Sector
Relationship
P/E Ratio
21.0x23.3x−0.5x
PEG Ratio
0.361.210.00
Price/Book
1.6x2.1x2.6x
Price / LTM Sales
1.5x2.8x3.2x
Upside (Analyst Target)
-38.4%47.8%
Fair Value Upside
Unlock25.2%5.9%Unlock

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, advanced patient monitoring, ICU infrastructure equipment, and drainage solutions. In addition, the company provides surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, vascular and cardiothoracic surgery equipment, peripheral stenting, OEM solutions, and beating heart surgery equipment; and operating room equipment, anesthesia, advanced patient monitoring, and operating room integration solutions. Further, it offers pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices, and patient flow management; and low temperature sterilization, biocontainment in vaccine production, terminal sterilization, sterile isolation technology, cleaning and sterilization, aseptic transfer, and large-scale cultivation. Additionally, the company provides bioreactor preparation solution, bioprocess development and optimization, labware cleaning and sterilization, biocontainment, and vivarium. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.

Employees
11754
Market
Sweden

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
33.34M12.24%6.13B
Other Institutional Investors
91.96M33.76%16.90B
Public Companies & Retail Investors
147.07M54.00%27.03B
Total
272.37M100.00%50.06B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Government Pension Fund Global2.10%5,722,3361,051,765
Vanguard STAR Funds - Vanguard Total International Stock ETF1.17%3,175,499583,657

People Also Watch

47.98
EURA
+0.88%
527.50
LUNDBs
0.00%
43.93
HUSQBs
+2.53%
77.30
FABGs
0.00%
123.00
CASTs
+4.19%

FAQ

What Is the Getinge B (BATS Europe: GETIBs) Share Price Today?

The Getinge B stock price today is 186.20 SEK.

What Stock Exchange Does Getinge B (GETIBs) Trade On?

Getinge B is listed and trades on the BATS Europe.

What Is the Ticker (Stock Symbol) for Getinge B?

The stock symbol (also called a 'ticker') for Getinge B is "GETIBs."

Does Getinge B Pay Dividends? What’s The Current GETIBs Dividend Yield?

Yes, GETIBs Pays Dividends to its Shareholders. The current Getinge B dividend yield is 2.55%.

What Is the Current Getinge B Market Capitalisation?

As of today, Getinge B (BATS Europe: GETIBs) market cap is 50.72B SEK.

What Is Getinge B's (GETIBs) Earnings Per Share (TTM)?

The Getinge B EPS is currently 8.66 (Trailing Twelve Months).

When Is the Next Getinge B Earnings Date?

Getinge B's next earnings report will be released on 17/07/2026.

Is GETIBs a Buy or Sell From a Technical Analyst Perspective?

Based on today's Getinge B moving averages and other technical indicators, the daily buy/sell signal for GETIBs stock is Strong Sell.

How Many Times Has Getinge B Stock Split?

Getinge B has split 3 times. (See the GETIBs stock split history page for full effective split date and price information.)

How Many Employees Does Getinge B Have?

Getinge B has 11754 employees, based on their latest Companies House report.

What is the current trading status of Getinge B (BATS Europe: GETIBs)?

As of 06/05/2026, Getinge B (GETIBs) is trading at a share price of 186.20 SEK, with a previous close of 186.20 SEK. The stock has fluctuated within a day range of 186.20 SEK to 186.20 SEK, while its 52-week range spans from 181.53 SEK to 227.40 SEK.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.